Fatal outcome of a patient with severe aplastic anemia after treatment with metenolone acetate
| Autor: | Takashi Uchiyama, Takuji Naruse, Yoichi Nakazato, Norifumi Tsukamoto, T. Takeuchi, Sadao Sato |
|---|---|
| Rok vydání: | 1993 |
| Předmět: |
Male
medicine.medical_specialty Side effect Methenolone Anemia medicine.medical_treatment Gastroenterology Internal medicine Cyclosporin a medicine Humans Aplastic anemia Metenolone acetate Aged Chemotherapy business.industry Anemia Aplastic Hematology General Medicine medicine.disease Surgery Hepatic Encephalopathy Complication business Metenolone medicine.drug |
| Zdroj: | Annals of Hematology. 67:41-43 |
| ISSN: | 1432-0584 0939-5555 |
| DOI: | 10.1007/bf01709665 |
| Popis: | A 75-year-old man suffering from severe aplastic anemia was treated first with cyclosporin A, then with steroid pulse therapy, and subsequently with metenolone acetate. Marked elevation of transaminases was detected following initiation of treatment with metenolone acetate. This was followed by hepatic failure and death. Histopathological findings in autopsy specimens were compatible with the diagnosis of drug-induced liver impairment, for which metenolone acetate was considered the most likely causative agent. Liver impairment as a side effect of the use of this drug has been thought to be mild, reversible and rather infrequent. However, as demonstrated in the case described here, it is apparent that extreme caution should be exercised when using this drug in debilitated patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink